Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Valeo Pharma Inc - Ordinary Shares (VPH $0.66)
- $0.66 Cap: $65M
- View VPH Profile
- View Questions on VPH
Q: Hi Peter and Ryan, What's your opinion of Valeo Pharma Inc?
thanks,
J
thanks,
J
-
Valeo Pharma Inc - Ordinary Shares (VPH $0.66)
- $0.66 Cap: $65M
- View VPH Profile
- View Questions on VPH
Q: Valeo's business model seems to be to acquire rights to drugs in niche markets that wouldn't appeal to the larger drug companies.
What would be your outlook on the company and its strategy. Many thanks.
What would be your outlook on the company and its strategy. Many thanks.
Insiders
Share Information
News and Media